Hepatectomy for Gallbladder Carcinoma

By -

 

Executive Summary

Gallbladder carcinoma (GBC) is the most prevalent malignancy of the bile duct system, characterized by high malignancy and a poor prognosis. With a five-year survival rate of only 5% and a median survival time of 8–10 months, GBC remains a formidable clinical challenge. Because GBC is largely resistant to radiotherapy and chemotherapy, surgical resection is the only curative intervention. The primary goal of surgery is to achieve an R0 resection margin, as patients with R1 or R2 margins face survival outcomes similar to those who receive no surgical intervention.

Successful management depends on precise clinical and pathological staging (primarily using the UICC TNM 7th edition or Nevin systems) and a deep understanding of anatomical variations. Surgical strategies range from simple cholecystectomy for early-stage (Tis/T1a) tumors to radical resections involving wedge hepatectomy, segmentectomy, or extended hemihepatectomy combined with the skeletonization of the hepatoduodenal ligament for more advanced stages.

1. Clinical Overview and Pathology

1.1 Incidence and Prognosis

  • Prevalence: GBC accounts for 80–95% of all malignant tumors in the bile duct system.

  • Global Impact: Approximately 2.2 out of every 100,000 people are diagnosed annually, ranking GBC sixth among all gastrointestinal malignancies.

  • Prognosis: The average expected lifespan after diagnosis is six months.

  • Anatomical Risk: The absence of serosa between the gallbladder and the liver, coupled with shared connective tissue, facilitates rapid metastasis from the gallbladder to the liver.

1.2 Risk Factors

The primary drivers of GBC include:

  • Cholelithiasis and chronic inflammation (e.g., Salmonella or Helicobacter infections).

  • Demographics: Amerindian ethnicity, female gender, and low socioeconomic status.

  • Lifestyle and Health: Obesity, smoking, and advanced age.

2. Anatomical Considerations for Resection

2.1 Extrahepatic Bile Duct Anomalies

Anomalies are frequent, most commonly involving the segment I bile duct entering the right, common hepatic, cystic, or common bile ducts. Accidental dissection of this duct can result in a daily bile flow exceeding 500 mL, necessitating immediate suturing.

2.2 Vascular Variations

The cystic artery presents anomalies in approximately one-third of the population.

  • Classic Distribution (2/3 of patients): A single cystic artery originates from the right hepatic artery within Calot’s Triangle, dividing into deep and shallow branches.

  • Variations (1/3 of patients): The artery may originate from the left hepatic, gastroduodenal, superior mesenteric, or celiac arteries. Double cystic arteries may also be present.

2.3 Lymphatic Drainage

The gallbladder wall features extensive drainage forming plexuses that divide into two primary pathways:

  1. Pathway 1: Neck of the gallbladder → common bile duct lymph nodes → behind pancreatic head and duodenum → mesenteric artery lymph nodes → nodes between the abdominal aorta and inferior vena cava.

  2. Pathway 2: Behind the portal vein → celiac artery lymph nodes → nodes between the abdominal aorta and inferior vena cava.

3. Staging Systems

3.1 Nevin Staging

Proposed in 1976, this system focuses on infiltration and diffusion:

  • Stage I: Carcinoma in situ (mucosa).

  • Stage II: Invasion of mucosa and muscle.

  • Stage III: Full-thickness invasion (mucosa, muscle, and serosa).

  • Stage IV: Full-thickness invasion with lymph node metastasis.

  • Stage V: Direct liver invasion, liver metastasis, or distant organ metastasis.

3.2 UICC TNM Staging (7th Edition)

This system classifies GBC based on tumor depth (T), regional lymph node involvement (N), and distant metastasis (M).

4. Surgical Treatment Principles

4.1 Curative vs. Palliative

  • Curative Therapy: Focused on early-stage cancers to achieve R0 margins.

  • Palliative Therapy: Reserved for advanced, incurable cases where radical resection is impossible.

  • Stage-Specific Strategies:

    • Tis and T1a: Cholecystectomy alone provides an excellent prognosis.

    • T1b: Use of radical cholecystectomy is supported by evidence, though extended resection remains debatable.

    • T2: Requires radical resection, including gallbladder removal, adjacent liver tissue, and skeletonized hepatoduodenal ligament.

    • T3: Requires liver resection and potentially the removal of adjacent violated organs (colon, duodenum, pancreas).

    • T4: Limited surgical opportunities; however, radical resection should be attempted if possible despite poor survival rates.

4.2 Preoperative Preparation

  1. Liver Function Assessment: Critical for patients with jaundice or those requiring major resection.

  2. Jaundice Management: If serum total bilirubin exceeds 256.5 μmol/L, Percutaneous Transhepatic Cholangial Drainage (PTCD) is used.

  3. Medical Optimization: Intravenous Vitamin K1 and fresh plasma to correct clotting; glutathione and Vitamin C/branched-chain amino acids for liver cell stability.

  4. Resectability Determination: Evaluation of hilar violation and abdominal metastases. Diagnostic laparoscopy is recommended before laparotomy.

5. Surgical Procedures and Techniques

5.1 Radical Liver Wedge Resection

Used for early GBC, this involves en bloc resection of the gallbladder and 2–4 cm of surrounding liver tissue.


  • Skeletonization:     Essential removal of all lymph nodes (groups 5, 7, 8, 9, and 12), nerves, fiber, and fat in the hepatoduodenal ligament and gallbladder triangle.

  • Ductal Management: The cystic duct is excised and margins are submitted for pathology. If tumor emboli are present, the main bile duct must be probed.

5.2 Segmentectomy and Hepatectomy

  • Segmentectomy (IVb and V): Indicated when tumor invasion into the liver parenchyma is deeper than 2 cm.

  • Regular Right Hepatic Lobectomy: Suitable for tumors in the gallbladder neck, invasion of the right portal vein, or multiple metastatic tumors in the right liver.

  • Extended Hemihepatectomy: Used when GBC invades parenchyma beyond segments 4 or 5, or when metastatic tumors are present throughout one lobe but the other remains clear.

5.3 Bile Duct Resection

Bile duct resection and Roux-en-Y hepaticojejunostomy are performed if:

  • The tumor invades the cystic duct.

  • The common bile duct is invaded (requires R0 resection margins).

  • Extended right hepatectomy is necessary to achieve clearance.